GlassScriptPhysician profile
Syed H Mehdi
NPI 1992762488
$4,037.26
in general payments reported to CMS, 2019-2025
11 companies · $1,230 in 2025
The $1,230 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $74.28 · 2022: $256 · 2023: $2,360 · 2025: $1,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,525 · Food and Beverage: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,524.63 |
| Food and Beverage | $1,065.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,048.30 | 2023-2025 | Mazor X System, Clydesdale Ptc Spinal System, Stealthstation S8 Platform |
| Globus Medical, INC. | $339.06 | 2023 | Creo 5.5, Excelsiusgps Robotic Navigation System, Elsa, Elsa Al/Atp |
| Centinel Spine, LLC | $140.05 | 2022 | |
| Cerapedics INC. | $125.69 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Boston Scientific Corporation | $117.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.28 | 2020 | |
| Inari Medical, INC. | $47.22 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $45.51 | 2023 | Exparel |
| Alvogen INC | $40.83 | 2022 | |
| Stryker Corporation | $31.45 | 2023 | N/A |
| Mylan Specialty L.P. | $27.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Mehdi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.